Weaver Kirke 4

Accession 0001821825-25-000010

CIK 0001821825other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:39 PM ET

Size

27.9 KB

Accession

0001821825-25-000010

Form 4

Period: 2025-03-31

Gen. Counsel & Corp. Secy.

Transactions

Exercise/Conversion
Common Stock
2025-03-31+7,757→ 36,917 total
Exercise/Conversion
Common Stock
2025-03-31+6,200→ 40,907 total
Tax Payment
Common Stock
2025-03-31$14.51/sh−1,224$17,760→ 44,444 total
Award
Restricted Stock Units
2025-03-31+36,937→ 36,937 total
→ Common Stock (36,937 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-31−6,200→ 6,200 total
→ Common Stock (6,200 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-31−4,294→ 0 total
→ Common Stock (4,294 underlying)
Tax Payment
Common Stock
2025-03-31$14.51/sh−1,767$25,639→ 39,140 total
Tax Payment
Common Stock
2025-03-31$14.51/sh−891$12,928→ 41,374 total
Exercise/Conversion
Restricted Stock Units
2025-03-31−3,125→ 0 total
→ Common Stock (3,125 underlying)
Tax Payment
Common Stock
2025-03-31$14.51/sh−2,210$32,067→ 34,707 total
Exercise/Conversion
Common Stock
2025-03-31+3,125→ 42,265 total
Exercise/Conversion
Common Stock
2025-03-31+4,294→ 45,668 total
Award
Stock Option (right to buy)
2025-03-31+181,518→ 181,518 total
Exercise: $14.89→ Common Stock (181,518 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-31−7,757→ 15,514 total
→ Common Stock (7,757 underlying)

Footnotes (8)

[F1]This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
[F2]The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
[F3]Each RSU converts into one share of Organon common stock.
[F4]The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
[F5]On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.
[F6]On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026.
[F7]On November 7, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.
[F8]On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.

Documents

1 file

Organon & Co.

CIK 0001821825

Entity typeother